337 - Daptomycin-Susceptible vs. Daptomycin-Non-susceptible Enterococcus Bloodstream Infections: Rates and Predictors of Treatment Failure and Predictors of Daptomycin Resistance

Co-Author(s)

• KO

  Kelsey Olion, Pharm.D.

  Clinical Pharmacy Specialist
  VA St. Louis HCS
  St. Louis, Missouri, United States

Rapid Fire Presenter(s)

• 

  Ryan P. Moenster, Pharm.D., FIDSA (he/him/his)

  Professor of Pharmacy Practice/Clinical Pharmacy Specialist
  St. Louis College of Pharmacy at UHSP/VA St. Louis HCS
  St. Louis, MO, United States

Co-Author(s)

• AW

  Ashleigh Wallace-Lacey, Pharm.D.

  VISN 15/VA HCS
  St. Louis, Missouri, United States
• BR

  Blake Remensnyder, Pharm.D.

  PGY2 Pharmacy Resident
  VA St. Louis HCS
  St. Louis, Missouri, United States
• TL

  Travis W. Linneman, Pharm.D.

  Associate Chief of Service
  VA St. Louis HCS
  St. Louis, Missouri, United States